Comparison of ketorolac and haloperidol in headache

Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2024
INTERVENTION: Intervention 1: Intervention group: Ketorolac prescription 30 mgr intravenous with 30 mgr/2mL ampoules by 5 cc syringes. Intervention 2: Intervention group2: Haloperidol receivers 1 mgr intravenous with 2mgr ampoules diluted in 5 cc sterile water in 5cc syringes. CONDITION: Headache. ; Other headache syndromes PRIMARY OUTCOME: Pain reduction. Timepoint: 15 , 30 , 60 mintes. Method of measurement: Visual analogue scale. INCLUSION CRITERIA: patients aged 18 to 55 who have visited the emergency room with the main complaint of headache.
Epistemonikos ID: cad0c7469a8a1d9e18c1c1d91c370072955147e4
First added on: Dec 06, 2024